vs
Side-by-side financial comparison of Alignment Healthcare, Inc. (ALHC) and Organon & Co. (OGN). Click either name above to swap in a different company.
Organon & Co. is the larger business by last-quarter revenue ($1.5B vs $1.2B, roughly 1.2× Alignment Healthcare, Inc.). Alignment Healthcare, Inc. runs the higher net margin — 0.9% vs -13.6%, a 14.5% gap on every dollar of revenue. On growth, Organon & Co. posted the faster year-over-year revenue change (-5.3% vs -74.7%). Over the past eight quarters, Alignment Healthcare, Inc.'s revenue compounded faster (34.6% CAGR vs -3.6%).
Alignment Healthcare, Inc. is a U.S.-based healthcare provider offering Medicare Advantage plans for seniors. It adopts a value-based care model, partnering with local providers to deliver personalized coordinated medical services, prescription drug coverage and supplemental benefits to members across multiple U.S. states.
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.
ALHC vs OGN — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.2B | $1.5B |
| Net Profit | $11.4M | $-205.0M |
| Gross Margin | — | 49.2% |
| Operating Margin | — | -9.8% |
| Net Margin | 0.9% | -13.6% |
| Revenue YoY | -74.7% | -5.3% |
| Net Profit YoY | — | -288.1% |
| EPS (diluted) | — | $-0.78 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.2B | — | ||
| Q4 25 | $1.0B | $1.5B | ||
| Q3 25 | $993.7M | $1.6B | ||
| Q2 25 | $1.0B | $1.6B | ||
| Q1 25 | $926.9M | $1.5B | ||
| Q4 24 | $701.2M | $1.6B | ||
| Q3 24 | $692.4M | $1.6B | ||
| Q2 24 | $681.3M | $1.6B |
| Q1 26 | $11.4M | — | ||
| Q4 25 | $-11.0M | $-205.0M | ||
| Q3 25 | $3.7M | $160.0M | ||
| Q2 25 | $15.7M | $145.0M | ||
| Q1 25 | $-9.1M | $87.0M | ||
| Q4 24 | $-31.1M | $109.0M | ||
| Q3 24 | $-26.4M | $359.0M | ||
| Q2 24 | $-24.0M | $195.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | 49.2% | ||
| Q3 25 | — | 53.5% | ||
| Q2 25 | — | 54.8% | ||
| Q1 25 | — | 55.6% | ||
| Q4 24 | — | 56.3% | ||
| Q3 24 | — | 58.3% | ||
| Q2 24 | — | 58.4% |
| Q1 26 | — | — | ||
| Q4 25 | -1.0% | -9.8% | ||
| Q3 25 | 0.8% | 15.2% | ||
| Q2 25 | 2.2% | 14.4% | ||
| Q1 25 | -0.6% | 6.7% | ||
| Q4 24 | -3.2% | 8.1% | ||
| Q3 24 | -2.8% | 13.1% | ||
| Q2 24 | -2.7% | 14.6% |
| Q1 26 | 0.9% | — | ||
| Q4 25 | -1.1% | -13.6% | ||
| Q3 25 | 0.4% | 10.0% | ||
| Q2 25 | 1.5% | 9.1% | ||
| Q1 25 | -1.0% | 5.8% | ||
| Q4 24 | -4.4% | 6.8% | ||
| Q3 24 | -3.8% | 22.7% | ||
| Q2 24 | -3.5% | 12.1% |
| Q1 26 | — | — | ||
| Q4 25 | $-0.04 | $-0.78 | ||
| Q3 25 | $0.02 | $0.61 | ||
| Q2 25 | $0.07 | $0.56 | ||
| Q1 25 | $-0.05 | $0.33 | ||
| Q4 24 | $-0.15 | $0.42 | ||
| Q3 24 | $-0.14 | $1.38 | ||
| Q2 24 | $-0.13 | $0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $705.6M | $574.0M |
| Total DebtLower is stronger | — | $8.6B |
| Stockholders' EquityBook value | $206.9M | $752.0M |
| Total Assets | $1.3B | $12.9B |
| Debt / EquityLower = less leverage | — | 11.49× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $705.6M | — | ||
| Q4 25 | $604.2M | $574.0M | ||
| Q3 25 | $644.1M | $672.0M | ||
| Q2 25 | $503.8M | $599.0M | ||
| Q1 25 | $479.5M | $547.0M | ||
| Q4 24 | $470.6M | $675.0M | ||
| Q3 24 | $381.0M | $763.0M | ||
| Q2 24 | $363.7M | $704.0M |
| Q1 26 | — | — | ||
| Q4 25 | $323.2M | $8.6B | ||
| Q3 25 | $322.7M | $8.8B | ||
| Q2 25 | $322.3M | $8.9B | ||
| Q1 25 | $321.9M | $9.0B | ||
| Q4 24 | $321.4M | $8.9B | ||
| Q3 24 | $212.0M | $8.7B | ||
| Q2 24 | $211.7M | $8.7B |
| Q1 26 | $206.9M | — | ||
| Q4 25 | $179.3M | $752.0M | ||
| Q3 25 | $161.9M | $906.0M | ||
| Q2 25 | $141.0M | $733.0M | ||
| Q1 25 | $108.1M | $542.0M | ||
| Q4 24 | $99.9M | $472.0M | ||
| Q3 24 | $114.5M | $493.0M | ||
| Q2 24 | $123.7M | $144.0M |
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.1B | $12.9B | ||
| Q3 25 | $1.1B | $13.6B | ||
| Q2 25 | $1.0B | $13.5B | ||
| Q1 25 | $895.6M | $13.2B | ||
| Q4 24 | $782.1M | $13.1B | ||
| Q3 24 | $692.3M | $12.8B | ||
| Q2 24 | $716.3M | $12.2B |
| Q1 26 | — | — | ||
| Q4 25 | 1.80× | 11.49× | ||
| Q3 25 | 1.99× | 9.74× | ||
| Q2 25 | 2.29× | 12.14× | ||
| Q1 25 | 2.98× | 16.52× | ||
| Q4 24 | 3.22× | 18.81× | ||
| Q3 24 | 1.85× | 17.75× | ||
| Q2 24 | 1.71× | 60.11× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $128.7M | $141.0M |
| Free Cash FlowOCF − Capex | — | $96.0M |
| FCF MarginFCF / Revenue | — | 6.4% |
| Capex IntensityCapex / Revenue | — | 3.0% |
| Cash ConversionOCF / Net Profit | 11.27× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $538.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $128.7M | — | ||
| Q4 25 | $-50.4M | $141.0M | ||
| Q3 25 | $144.6M | $264.0M | ||
| Q2 25 | $29.1M | $220.0M | ||
| Q1 25 | $16.6M | $75.0M | ||
| Q4 24 | $-8.7M | $390.0M | ||
| Q3 24 | $26.2M | $141.0M | ||
| Q2 24 | $23.5M | $332.0M |
| Q1 26 | — | — | ||
| Q4 25 | $-55.4M | $96.0M | ||
| Q3 25 | $139.1M | $218.0M | ||
| Q2 25 | $21.1M | $181.0M | ||
| Q1 25 | $8.4M | $43.0M | ||
| Q4 24 | $-18.0M | $335.0M | ||
| Q3 24 | $16.9M | $99.0M | ||
| Q2 24 | $11.8M | $300.0M |
| Q1 26 | — | — | ||
| Q4 25 | -5.5% | 6.4% | ||
| Q3 25 | 14.0% | 13.6% | ||
| Q2 25 | 2.1% | 11.4% | ||
| Q1 25 | 0.9% | 2.8% | ||
| Q4 24 | -2.6% | 21.0% | ||
| Q3 24 | 2.4% | 6.3% | ||
| Q2 24 | 1.7% | 18.7% |
| Q1 26 | — | — | ||
| Q4 25 | 0.5% | 3.0% | ||
| Q3 25 | 0.6% | 2.9% | ||
| Q2 25 | 0.8% | 2.4% | ||
| Q1 25 | 0.9% | 2.1% | ||
| Q4 24 | 1.3% | 3.5% | ||
| Q3 24 | 1.3% | 2.7% | ||
| Q2 24 | 1.7% | 2.0% |
| Q1 26 | 11.27× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 38.77× | 1.65× | ||
| Q2 25 | 1.86× | 1.52× | ||
| Q1 25 | — | 0.86× | ||
| Q4 24 | — | 3.58× | ||
| Q3 24 | — | 0.39× | ||
| Q2 24 | — | 1.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
